封面
市場調查報告書
商品編碼
1977584

全球血清分離膠市場規模、佔有率、趨勢和成長分析報告(2026-2034年)

Global Serum Separation Gels Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 139 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計血清分離凝膠市場將從 2025 年的 66.5 億美元成長到 2034 年的 118.4 億美元,2026 年至 2034 年的複合年成長率為 6.62%。

由於診斷檢查室對高效血液樣本處理的需求不斷成長,全球血清分離膠市場正經歷穩定成長。這些凝膠在臨床檢測中至關重要,能夠實現血清和血球的清晰分離。慢性病發病率的上升和定期健康檢查的普及推動了市場擴張。醫療基礎設施的改善也是全球需求成長的重要因素。

成長要素包括診斷設備和自動化技術的進步。檢查室需要可靠的樣本製備解決方案來確保準確性和效率。醫院網路和實驗室的擴張也促進了檢測需求的成長。此外,預防醫學意識的提高也推動了檢測頻率的增加。

隨著全球診斷檢測量的不斷成長,未來前景十分光明。凝膠成分的創新以及與先進分析儀器兼容性的提升將進一步提高其性能。新興經濟體對醫療保健現代化的投入也帶來了新的成長機會。隨著全球診斷需求的成長,市場預計將穩步擴張。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章:全球血清分離膠市場:依應用領域分類

  • 市場分析、洞察與預測
  • 臨床診斷
  • 血庫
  • 研究
  • 製藥

第5章 全球血清分離膠市場:依產品類型分類

  • 市場分析、洞察與預測
  • 管式血清分離膠
  • 不含試管的血清分離膠

第6章 全球血清分離膠市場:依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 診斷檢查室
  • 血庫
  • 研究機構
  • 製藥公司

第7章 全球血清分離膠市場:依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 亞太其他地區
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第9章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • BD
    • Greiner Bio-One
    • Sarstedt AG & Co. KG
    • Terumo Corporation
    • Thermo Fisher Scientific Inc
    • Fresenius Kabi AG
    • Qiagen NV
    • Nipro Corporation
    • Cardinal Health Inc
    • Bio-Rad Laboratories
簡介目錄
Product Code: VMR11211405

The Serum Separation Gels Market size is expected to reach USD 11.84 Billion in 2034 from USD 6.65 Billion (2025) growing at a CAGR of 6.62% during 2026-2034.

The Global Serum Separation Gels market has witnessed steady growth due to rising demand for efficient blood sample processing in diagnostic laboratories. These gels are essential in clinical testing, enabling clear separation of serum from blood cells. Increasing prevalence of chronic diseases and routine health screenings have boosted market expansion. Growth in healthcare infrastructure further supports demand globally.

Growth drivers include technological advancements in diagnostic equipment and automation. Laboratories require reliable sample preparation solutions to ensure accuracy and efficiency. Expanding hospital networks and research institutions also contribute to rising consumption. Additionally, growing awareness about preventive healthcare strengthens testing frequency.

Future prospects appear promising as diagnostic testing volumes increase worldwide. Innovations in gel composition and improved compatibility with advanced analyzers will enhance performance. Emerging economies investing in healthcare modernization offer new growth avenues. The market is expected to expand steadily with rising global diagnostic needs.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

  • Clinical Diagnostics
  • Blood Banking
  • Research
  • Pharmaceuticals

By Product Type

  • Serum Separation Gel Integrated With Tube
  • Serum Separation Gel Without Tubes

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Blood Banks
  • Research Institutions
  • Pharmaceutical Companies

COMPANIES PROFILED

  • BD, Greiner BioOne, Sarstedt AG Co KG, Terumo Corporation, Thermo Fisher Scientific Inc, Fresenius Kabi AG, Qiagen NV, Nipro Corporation, Cardinal Health Inc, BioRad Laboratories
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL SERUM SEPARATION GELS MARKET: BY APPLICATION 2022-2034 (USD MN and Units)

  • 4.1. Market Analysis, Insights and Forecast Application
  • 4.2. Clinical Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 4.3. Blood Banking Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 4.4. Research Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 4.5. Pharmaceuticals Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 5. GLOBAL SERUM SEPARATION GELS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN and Units)

  • 5.1. Market Analysis, Insights and Forecast Product Type
  • 5.2. Serum Separation Gel Integrated With Tube Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 5.3. Serum Separation Gel Without Tubes Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 6. GLOBAL SERUM SEPARATION GELS MARKET: BY END USER 2022-2034 (USD MN and Units)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 6.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 6.4. Blood Banks Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 6.5. Research Institutions Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
  • 6.6. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 7. GLOBAL SERUM SEPARATION GELS MARKET: BY REGION 2022-2034(USD MN and Units)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
    • 7.2.1 By Application
    • 7.2.2 By Product Type
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
    • 7.3.1 By Application
    • 7.3.2 By Product Type
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
    • 7.4.1 By Application
    • 7.4.2 By Product Type
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
    • 7.5.1 By Application
    • 7.5.2 By Product Type
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
    • 7.6.1 By Application
    • 7.6.2 By Product Type
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL SERUM SEPARATION GELS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 BD
    • 9.2.2 Greiner Bio-One
    • 9.2.3 Sarstedt AG & Co. KG
    • 9.2.4 Terumo Corporation
    • 9.2.5 Thermo Fisher Scientific Inc
    • 9.2.6 Fresenius Kabi AG
    • 9.2.7 Qiagen NV
    • 9.2.8 Nipro Corporation
    • 9.2.9 Cardinal Health Inc
    • 9.2.10 Bio-Rad Laboratories